Generics - USA, Markets & Marketing

Filter

Current filters:

USAMarkets & Marketing

Popular Filters

Generic versions of Valcyte and Activella hit the US market

20-11-2014

Ireland-domiciled pain drugmaker Endo International says that its Qualitest subsidiary has launched a…

ActivellaAmneal PharmaceuticalsEndo InternationalGenericsLopreezaMarkets & MarketingNovo NordiskOphthalmicsRocheUSAValcyteWomen's Health

Mylan debuts generic Viramune XR in USA

Mylan debuts generic Viramune XR in USA

31-10-2014

US generic drugmaker Mylan said yesterday that it has launched its nevirapine extended-release tablets,…

Anti-viralsBoehringer IngelheimGenericsMarkets & MarketingMylanUSAViramune

Mylan debuts generic of ViiV’s Combivir in USA

Mylan debuts generic of ViiV’s Combivir in USA

06-10-2014

US generic drugmaker Mylan has launched of its Lamivudine and Zidovudine Tablets USP, 15mg/300mg, which…

Anti-viralsCombivirGenericsGlaxoSmithKlineMarkets & MarketingMylanUSAViiV Healthcare

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Teva launches generic Baraclude in the USA

Teva launches generic Baraclude in the USA

04-09-2014

Israeli generics giant Teva Pharmaceutical Industries says it has launched its generic equivalent to…

Anti-viralsBaracludeBristol-Myers SquibbGenericsMarkets & MarketingTeva Pharmaceutical IndustriesUSA

Mylan launches first generic Klor-Con extended-release tablets

Mylan launches first generic Klor-Con extended-release tablets

22-08-2014

US generic drugs major Mylan said today that it has launched potassium chloride extended-release tablets…

GenericsKlor-ConMarkets & MarketingMetabolicsMylanUpsher-SmithUSA

Amneal Pharma launches four new generics

Amneal Pharma launches four new generics

14-08-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals’ fast-growing portfolio of approved generic…

AcyclovirAmneal PharmaceuticalsCleocinGenericsMarkets & MarketingMepronRoxicodoneUSAZovirax

Sanofi unit launches authorized generic of Eloxatin

Sanofi unit launches authorized generic of Eloxatin

12-08-2014

The US subsidiary of French pharma major Sanofi says it has launched an authorized generic version of…

Advanced colorectal cancerEloxatinGenericsMarkets & MarketingOncologyOxaliplatinSanofiUSA

Impax Labs receives subpoena over digoxin

Impax Labs receives subpoena over digoxin

16-07-2014

US generic drugmaker Impax Laboratories revealed in a Securities Exchange Commission filing that, on…

Cardio-vascularCardiologydigoxinGenericsImpax LaboratoriesLegalMarkets & MarketingUSA

Mylan launches generic Micardis in USA

Mylan launches generic Micardis in USA

08-07-2014

US generic drugmaker Mylan has launched Telmisartan Tablets USP, 20mg, 40mg and 80mg, the generic version…

Boehringer IngelheimCardio-vascularGenericsMarkets & MarketingMicardisMylanRegulationTelmisartanUSA

Mylan launches generic Paraplatin Injection in USA

Mylan launches generic Paraplatin Injection in USA

09-06-2014

US generics major Mylan has launched carboplatin injection, 50mg/5ml, in multi-dose vials, which is the…

Bristol-Myers SquibbGenericsMarkets & MarketingMylanOncologyParaplatinRegulationUSA

Report highlights approvals, challenges and deals in the generics sector

Report highlights approvals, challenges and deals in the generics sector

09-06-2014

India-based groups received the most approvals for Abbreviated New Drug Applications from the US Food…

GenericsMarkets & MarketingUSA

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

14-05-2014

US generic drugmaker Mylan says it has launched Olanzapine Orally Disintegrating tablets (ODT), 5mg,…

ActavisEli LillyExalgoGenericsMallinckrodtMarkets & MarketingMylanNeurologicalRegulationUSAZyprexa

Actavis debuts generic copy of Catapres-TTS

Actavis debuts generic copy of Catapres-TTS

08-05-2014

Ireland-headquartered generics major Actavis has launched a generic version of German family-owned pharma…

ActavisBoehringer IngelheimCardio-vascularCatapres-TTSGenericsMarkets & MarketingUSA

Teva launches first generic Lovaza in USA

Teva launches first generic Lovaza in USA

08-04-2014

Israel-based Teva Pharmaceutical Industries says it has received US Food and Drug Administration approval…

Cardio-vascularGenericsGlaxoSmithKlineLovazaMarkets & MarketingRegulationTeva Pharmaceutical IndustriesUSA

Prasco to market the authorized generic of Lilly’s Evista in USA

01-04-2014

Privately-held US generics firm Prasco has signed a further deal with US pharma major Eli Lilly to market…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsMarkets & MarketingNorth AmericaPrasco LaboratoriesUSA

Lupin launches generic Niaspan in USA

24-03-2014

Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Amneal debuts generic Esomeprazole strontium in USA

07-01-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Teva launches authorized generic of Detrol in USA

Teva launches authorized generic of Detrol in USA

04-01-2014

Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it has launched…

Detrol LAGenericsGenito-urinaryMarkets & MarketingNorth AmericaPfizerTeva Pharmaceutical IndustriesUSA

US FTC rescheduled workshop on state regulations and naming conventions set for February

31-12-2013

The US Federal Trade Commission announced its one-day public workshop on competition and follow-on biologics,…

BiosimilarsGenericsMarkets & MarketingNorth AmericaRegulationUSA

Back to top